Results 141 to 150 of about 149,229 (299)
Metrnβ serves as a novel prognostic biomarker for sepsis and that targeted blockade of the Metrnβ‐c‐Kit axis represents a promising therapeutic strategy for sepsis. Abstract Sepsis is a heterogeneous syndrome critically driven by immunosuppression, yet lacking personalized prognostic markers and therapeutic targets. Here, we provide evidence to support
Xiao Li +15 more
wiley +1 more source
Background. Inguinal hernia repair is one of the most common surgical procedures performed in the world and as that represents a huge socio-economic problem.
Bojan Krebs +3 more
doaj
Effect of Laparoscopic Inguinal Hernia Repairs on Inflammatory Factors, Oxidative Stress Levels and Postoperative Recovery [PDF]
Bo Yang, Changhu Xie, Yuxing Lv, Yinquan Wang Department of Hernia and Abdominal Wall Surgery, Shanxi Bethune Hospital, Shanxi Academy of Medical Science, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, Shanxi, 030032 ...
Lv Y, Yang B, Wang Y, Xie C
core
Abstract Objectives Adalimumab biosimilars are as safe and effective compared to the originator. Adult patients with inflammatory bowel disease (IBD) who switched to a biosimilar have comparable outcomes, but pediatric data are limited. This study evaluates clinical outcomes of children and young adults with IBD following a nonmedical, insurance‐driven
Daniel Himelstein +5 more
wiley +1 more source
Inguinal Lymph Node Metastasis from a Sigmoid Stomal Cancer: A Case Report. [PDF]
Shirakawa K +10 more
europepmc +1 more source
ABSTRACT Introduction Sarcomas are rare malignancies that affect both adults and children. Surgical removal with negative histopathological margins is the foundation of sarcoma treatment. Failure to achieve negative margins puts patients at risk of local recurrence (LR). LR rates range between 10% and 30%.
Sumail Bhogal +13 more
wiley +1 more source
Capsule Summary Xeroderma pigmentosum (XP) is associated with a high risk of multiple and aggressive cutaneous squamous cell carcinomas (CSCCs). The immune checkpoint inhibitor cemiplimab has been approved in advanced, unresectable, and/or metastatic CSCCs.
Sudip Parajuli +5 more
wiley +1 more source
A rare guest in the hernia sac: Preoperatively diagnosed Amyand's hernia with gangrenous appendicitis. [PDF]
Baz C, Connors K, Siddiqui S.
europepmc +1 more source
Minimally invasive inguinal hernia repair: back to the future
Edward L. Felix
doaj +1 more source
Rare Groin Hernias With Unusual Sac Contents: A Systematic Review of Anatomical Variants and Surgical Implications. [PDF]
Filippou CP +3 more
europepmc +1 more source

